Cyxone’s executive management team consists of experienced experts with solid knowledge in the fields of drug development, business development and financing in innovative biotech companies.

Tara Heitner


Born 1969. CEO since 2020.


Tara Heitner has more than 20 years’ experience from R&D, management and board positions in the biotech and pharma industry. Her previous roles include CEO, Business Development Director and Scientist. In 2014 Tara founded her own consultancy company, Heitner Biopharm Consultation, focusing on strategic, financing and business development advice for small biotech companies and start-ups. Tara is the co-founder of a number of start-ups spun out from universities such as Lund University, Sweden and Aarhus University, Denmark. Tara has successfully closed several partnership deals and been successful in fundraising. She holds a Ph.D. in chemistry from McGill University in Canada and an MBA from Technical University of Denmark (DTU).

Other assignments:

  • Board Member in Nordic Pharmaceutical Licensing Group
  • Board Member in Bainan Biotech
  • Part-time CEO in ISD Immunotech

Shares in the company (as per 4 March 2021)

Tara Heitner owns 33,660 shares in Cyxone.

Ola Skanung


Born 1964. CFO since 2015.


Ola Skanung holds a B.Sc. in Business Administration and Entrepreneurship and additional exams within Financial Law and Change Management. He has many years of experience as CFO and from working with start-ups and growth projects within the private sector, as well as with state and regional development actors.

Other assignments

  • CEO and Board Member in Ledningsresurs Syd AB
  • CFO in Aptahem AB
  • Board Member in XO Sweden Wines & Spirits AB
  • Liquidator in Ideonfonden AB

Shares in the company (as per 3 December 2020)

Ola Skanung owns 28,700 shares in Cyxone.

Malin Berthold


Born 1963. COO since 2020.


Malin Berthold holds a Ph.D. in neurochemistry from Stockholm University, Sweden, and has more than 20 years’ experience from the pharmaceutical and medtech industries in different leading and expert roles. At Biovitrum AB she successfully led early discovery projects in metabolic disease, and headed biology teams in preclinical development, responsible for preparation for Phase 1 clinical trials. Malin co-founded and worked as senior consultant in a consultancy firm that supports small and medium-sized life science businesses with project management and scientific evaluations. As a senior scientific advisor in Global Marketing at ThermoFisher Scientific she was responsible for scientific and medical evidence, clinical study strategy and key opinion leader relations in allergy and asthma.

Shares in the company (as per 3 December 2020)

Malin Berthold owns 13,500 shares in Cyxone


Rhea Rodeo

Administrator/CEO assistant

Rhea Rodeo has many years of work experience as HR assistant, Secretary, Administrator, and Project Administrator. Before joining Cyxone, she worked at large international companies in Sweden, such as Westinghouse and IKEA. At Cyxone, Rhea Rodeo is responsible for general administration and provides support and assistance to the CEO and CFO.

Phone: +46 708 88 21 72